June 5, 2008
Ultrasonix's Winning Combination Results in Multi-system Installations in Infertility and IVF Clinics
Read full release
May 6, 2008
Ultrasonix Medical Corporation Restructures North American Operations
Read full release
April 21, 2008
Ultrasonix Medical Corporation Credits a Great 2008 start to EPI Extended Pulse Imaging Technology – A Significant Advance in Diagnostic Ultrasound.
Read full release
January 21, 2005
Ultrasonix Medical Corp. Granted ISO 13485:2003 Certification
Burnaby, BC (January 21, 2005) – Leading ultrasound equipment manufacturer Ultrasonix Medical Corporation is pleased to announce that its management system has been granted ISO 13485:2003 certification by QMI, North America's premier management system registrar.
A new addition to the international medical device standards, ISO 13485:2003 aims to facilitate harmonized medical device regulatory requirements for quality management systems.
In accepting the certificate, Laurent Pelissier, Founder and Chief Technical Officer of Ultrasonix Medical Corp. stated, "At Ultrasonix we feel it is critical to maintain and exceed international quality standards. ISO 13485:2003 certification is an important milestone for the company and our customers, proving our commitment to ensuring the highest quality of design and assembly of our diagnostic ultrasound equipment."
About QMI:
QMI is North America 's leading management system registrar, offering registration to a wide range of ISO and industry specific standards. Over the past 20 years, more than 8,000 manufacturing and service firms spanning a broad spectrum of industry sectors have received certification from QMI. A subsidiary of CSA Group, QMI reflects CSA's focus of putting standards to work for people and businesses. Further information can be found at www.qmi.com.
About Ultrasonix Medical Corporation:
A privately held company based in Burnaby, British Columbia, focuses on development and manufacturing of high quality diagnostic ultrasound imaging systems. The company develops a patented ultrasound platform that not only delivers first-rate clinical performance, it also defines a new industry standard for cost-performance. Ultrasonix's unique, patented Open Sonix® computer-based ultrasound platform allows for rapid development of novel ultrasound imaging techniques and new advanced features by leveraging the open architecture and its programmable 82GOps Processing Unit. Further information is available at www.ultrasonix.com.
Contact:
Rossa Sung, Global Marketing Manager
Ultrasonix Medical Corporation
301-3480 Gilmore Way
Burnaby, BC, Canada
V5G 4Y1
[t] 604.437.9500
[f] 604.437.9502
[e] info@ultrasonix.com
[w] www.ultrasonix.com